Is It Normal Not to Lose Weight on Mounjaro? (October 2026)

01 · The core answer

Is it normal not to lose weight on Mounjaro?

Yes, within limits. Weight loss on Mounjaro is gradual by design, and many people see little change in the early weeks. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ If you are still on the starter dose, or you have only just moved up a strength, a quiet scale does not mean the treatment has failed.

It is also normal for experiences to differ widely. Some people notice appetite change and early loss in week one, while others feel little until a higher dose. Both are normal.¹ Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.

The pattern that deserves attention is different. If you have been on the highest dose you can tolerate for a sustained period and the trend is still flat, that is a conversation for your prescriber, not something to fix on your own. Our guide on whether you can fail to lose weight on Mounjaro covers the rarer cases in more depth.

02 · Where are you?

Which situation are you in?

The right response depends on where you are in treatment.

03 · Next step

What to do next

Start by working out which row you are in. If you are early in treatment, patience and honest tracking are the main tools. If you are further along, a review of what you eat, how you sleep and how active you are usually comes before any change of dose, and your prescriber is the person to decide on a step-up.

If you are already a customer, our prescribing team carries out ongoing monthly reviews and dose-titration, so use them. If you are still researching, our weight loss clinic page explains how treatment works, and you can see current options for the Mounjaro pen, where in stock applies to all six doses. The 2.5mg pen has a standard price of £169.99 per month; new customers save £40 on their first order with code FIRST40, and every later order is £25 off the standard price.

Whatever you decide, remember that Mounjaro is prescription-only, supplied after an online consultation reviewed by a GPhC-registered prescriber, and used alongside a reduced-calorie diet and increased physical activity. Individual results vary.¹

Related guide: Is it normal to put on weight on mounjaro.

04 · The first weeks

The first weeks on 2.5mg: what is normal

The starting weeks on 2.5mg are about adjustment, not about driving weight down. Experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal.¹ If your scale has barely moved, you are not unusual.

The 2.5mg strength exists so your body can get used to the medicine. Mounjaro is a once-weekly injection from a pre-filled KwikPen that comes in six strengths, and treatment steps up through them rather than starting at the top.¹ That means the early weeks are, by design, the lowest-effect part of the journey.

Early readings on the scale can also mislead. Early loss includes water weight, so a quick drop in week one followed by a pause does not mean the treatment has stopped working, and a slow week one does not mean it will never work.¹ What matters is the trend across weeks, not any single weigh-in. Weighing daily and reacting to each number is one of the most common ways people talk themselves into believing nothing is happening.

Side effects are part of the same picture. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹ If your appetite feels different but the scale is not moving yet, that is still a sign the medicine is active. The most common side effects, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort, and for most people they ease within days to a few weeks as the body adjusts.

It helps to set expectations before you begin. Treat the first weeks as a settling-in period in which you build habits: regular meals, enough protein, a routine for your injection day and a simple way of recording your weight. If you build these habits early, you will be in a far better position when you reach the doses where most measurable progress builds.

Practical steps for this phase include weighing at a consistent time once a week rather than daily, noting your appetite and any side effects, and avoiding the temptation to ask for a higher dose before the schedule allows. Dose changes are decided by your prescriber, not by how impatient you feel. If you are unsure whether what you are experiencing is normal, our page on why someone might not lose weight on Mounjaro goes through the common reasons, and your prescriber can help you interpret the details.

If something feels wrong rather than merely slow, speak to your prescriber. For severe or persistent stomach pain, swelling of the face, lips, tongue or throat, difficulty breathing or yellowing of the skin or eyes, get medical help straight away. You can also report suspected side effects through the Yellow Card scheme.¹⁹

05 · Pace by three months

What to expect by three months

By three months most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures. In SURMOUNT-1, average weight loss built month by month, with the full averages measured at 72 weeks, not at the three-month mark.² A sensible three-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.²

That wide variation matters. Some people will be ahead of that expectation and some behind it, and both groups can go on to do well. Slower early progress does not predict failure, because the dose you respond to may still be ahead of you.¹

Think in months, not days. Weight loss on Mounjaro is gradual by design, and trials measured results at 72 weeks, so the sensible way to judge progress is by trend rather than by individual weigh-ins.¹ A line drawn through several weeks of readings tells you far more than any one morning.

If you want a simple method, record your weight once a week at the same time of day, under the same conditions, and look at the direction over a month or more. Add measurements that do not depend on the scale, such as how your clothes fit and your waist size. Trials found average improvements in waist size alongside weight change, so a changing tape measure can be an early sign even when the scale is slow.²

It is also worth remembering what the trial numbers describe. They are averages across thousands of people, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Your own trajectory could sit above or below the average at any given point, and a three-month snapshot is a poor basis for deciding the medicine is not for you.

People often compare themselves with others online, and that is rarely helpful. Different starting weights, different doses, different timings and different habits all change what a given month looks like. The fairer comparison is you against your own baseline, tracked patiently.

Until then, the practical advice is to stay consistent. Keep your injection day regular, keep eating enough protein, stay active in ways you can sustain, and keep in touch with your prescriber about whether a step-up is appropriate.

06 · Plateaus

Plateaus: why the scale stops moving

Weight loss on Mounjaro is not linear, and plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹ If you lost steadily and then stopped, you are in the most common situation people ask about, and in most cases it is not a sign that anything has gone wrong.

The licensed approach to a plateau has several parts. First, review food intake honestly, because portions drift back up over time without anyone noticing. Second, protect protein and activity. Third, check the basics such as sleep and alcohol. Fourth, discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹

Honest review of intake is the step people find hardest. Appetite suppression is not the same as a calorie deficit, and the medicine helps most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ It supports the diet; it does not replace it. Liquid calories, small snacks that feel too minor to count, and larger portions of whatever you do eat can quietly cancel out the benefit of a smaller appetite.

A short written record for a week or two, covering what you ate and drank, is often more revealing than any amount of guessing. You do not need to keep it up forever; the aim is to spot where intake has crept back up. Many people who feel they are barely eating discover, once they write it down, that a few calorie-dense items are doing the work.

It is also common to find that very low intake brings its own problems with tiredness and with keeping up activity. Protecting protein and activity is part of the licensed advice for a reason, so aim for regular meals that you can sustain rather than eating as little as possible.

Sleep and alcohol deserve a mention too. Poor sleep can make appetite harder to manage, and alcohol adds calories without much sense of fullness. Neither is dramatic, but both are on the checklist for a reason.

What a plateau is not, is a reason to take matters into your own hands. A plateau is not a reason to double doses or add unlicensed products.¹ Taking extra medicine or combining it with unregulated products carries risks that the licence was never tested for. If you want to know more about stalls in different situations, our page for those who did not lose weight on Mounjaro looks at the next steps in more detail.

Finally, be patient with the process. A pause of a few weeks, followed by a resumed trend, is a normal shape for a weight-loss curve. The question to ask is not whether this week was a good week, but whether the last few months show movement in the right direction.

07 · What trials show

What the trials say about response

Most participants in the main obesity trial lost meaningful weight, but averages hide a wide spread of individual outcomes. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² The word average is doing a lot of work: some people lose more than the number, some less, and the trial reports the spread rather than a promise for any one person.

On the question of how many people respond, the trial gives a useful reading. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Put plainly, most people on treatment reached a clinically meaningful loss, and the figures were higher on higher doses.

The same trial reported that half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² These are the strong responders, and they are a reminder that results sit along a range.

Another point worth keeping in mind is timing. The SURMOUNT-1 figures were measured at 72 weeks. Judging the medicine at a few weeks, or even a few months, compares your early progress with an endpoint that is far away.

Finally, be careful about comparing numbers across different trials or different medicines. Each trial enrolled different people with different conditions and different designs, so one trial's average is not a target set by another. For your own plan, use your prescriber's review rather than trial headlines as the benchmark.

08 · How it works

How Mounjaro works, and what it cannot do for you

Mounjaro supports weight loss by changing appetite, not by burning fat on its own. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ The key phrase there is supports a reduced-calorie diet. The medicine makes it easier to eat less; the reduced intake is what drives the change on the scale.

That is why the licence describes use alongside a reduced-calorie diet and increased physical activity.¹ When people tell us they feel they are not eating much but the scale will not move, the useful questions are about what they are eating and drinking across a full week, not about whether the medicine is active. Appetite can change while intake is still higher than expected, particularly if food choices shift towards softer, calorie-dense options that are easy to eat in small amounts.

The slowed stomach emptying can also change how meals feel. Some people find large meals uncomfortable and move to smaller, more frequent snacks, which can add up. It is worth looking at the pattern across the whole day rather than only at the size of main meals.

Another reason progress may seem slow is dose. Tirzepatide is delivered in six strengths, from 2.5mg to 15mg, and the lowest is a starting dose.¹ Most measurable progress builds from 5mg onward. If you are comparing yourself with someone on a high dose, you are not comparing like with like.

Is anyone resistant to the medicine? Individual responses differ. That is a clinical judgement for your prescriber, based on your dose, how long you have been on it and your overall picture, not something you can diagnose from a few weighs. If you are curious about the topic more broadly, our page on whether anyone does not lose weight on Mounjaro covers this.

Finally, know the limits of what you can speed up. The medicine has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

09 · When to speak up

When to speak to your prescriber

Speak to your prescriber whenever progress has been flat for a sustained period on the highest dose you tolerate, and sooner if something feels wrong. There is a formal point for this review in NICE guidance. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹

That review is a conversation, not a verdict. Your prescriber will look at your dose, how consistently you have taken the medicine, what you are eating and drinking, your activity, your sleep, and how you feel. The outcome may be to continue, to adjust, or to stop, and the decision is made with you.

You do not need to wait for the formal review to ask a question. If you are not yet at the maximum dose, a plateau is a reason to discuss whether a dose step-up is appropriate.¹ Do not step up on your own, and do not double up. Taking more than prescribed is not within the licence.

What if you are restarting? Some people stop treatment and later return, and then find it does not seem to work as before. The sensible route is the same: tell your prescriber about the gap, because the dose you restart on is a clinical decision, and an earlier higher dose is not necessarily where you resume. Honest information about how long you stopped and what has changed in your routine helps them decide.

Also tell your prescriber about other medicines you take and any changes to your health, because these can affect how treatment is planned. Because Mounjaro slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start treatment or increase the dose, so mention everything you take, especially warfarin or other narrow-margin medicines, insulin or sulfonylureas, where doses may need reducing to avoid low blood sugar.

Bring something concrete to the conversation. A few weeks of weekly weights, a short food and drink diary, and notes on side effects make a review more useful than general impressions. You might also note when you inject, how you feel in the days afterward, and whether your appetite has changed over time.

If you are an EverydayMeds customer, ongoing monthly reviews, dose-titration and follow-up assessments are carried out by our prescribing team, with side-effect support, and repeat orders re-check suitability. Our support team is available Monday to Friday, 9am to 5pm, on email at support@everydaymeds.co.uk or by phone on 0333 207 0413.

Finally, if you notice a new symptom that worries you, speak to your prescriber and consider reporting it through the Yellow Card scheme.¹⁹ You do not need to be certain the medicine caused it to report it.

10 · Beyond the scales

Progress that does not show on the scales

The scale is only one measure, and it can lag behind other changes. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises, but they are why prescribers talk about weight management as health management rather than appearance.

This matters when you feel stuck. If your weight has been steady for some weeks but your clothes fit differently, your waist measurement has changed, or your health check results have improved, the treatment may be doing more than the number suggests. Asking your prescriber or GP about blood pressure, cholesterol or blood-sugar readings can give you a fuller picture than the scale alone.

It also helps to choose a handful of measures to follow and to stick with them. A weekly weight at a consistent time, a monthly waist measurement taken at the same point, and notes on energy, appetite and how comfortable you feel in daily life will give you a richer record than a single number. When you review progress with your prescriber, that record is easier to interpret than a series of scattered weights.

The trial context supports patience here. Trials measured results at 72 weeks, and the benefits were reported across several measures, not just weight.² Maintaining treatment over time was also studied in a separate trial that looked at continued treatment for keeping weight off, SURMOUNT-4, reported in JAMA.¹⁴

Keep your expectations realistic on the other side as well. Not every improvement will be visible week to week, and no measure on its own tells the whole story. But if you are doing the basics, staying in touch with your prescriber, and tracking more than the scale, you will be in a much better position to tell whether treatment is working for you.

For wider context on how to approach a weight management plan, see our weight loss clinic overview. And if you wonder whether the experience of a flat scale is something others report, our page on whether it is possible not to lose weight on Mounjaro addresses that directly.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

12 · NHS and private care

NHS and private routes if progress is slow

Whichever route you use, review and follow-up should be part of treatment. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you are on the NHS and progress is slow, your GP or the weight-management service that supports your care is the right place to discuss it. If you are on private treatment, the pharmacy and prescriber you use should offer the same kind of review, and you should expect to be asked about dose, adherence, diet and activity before any change is made.

With EverydayMeds, the process begins with a free online consultation, a short health questionnaire with no charge and no obligation. It is reviewed by a GPhC-registered prescriber, not a scoring script; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Dispensing is by our registered pharmacy (GPhC 9012878), with same-day dispatch when ordered by 3pm, and delivery is free next-day tracked in temperature-controlled packaging. Our Mounjaro is supplied through official LillyDirect supply, with genuine KwikPens, and needles, a sharps bin and injection guidance are included with every order.

To plan your costs, use the standard prices. The 2.5mg starting pen is £169.99 per month and the 5mg pen is £218.99. These are standard prices; new customers save £40 on their first order at any dose with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). The consultation is free and the price shown is the price paid, with no hidden fees. Prices were checked 11 October 2026. You can see the full range on the Mounjaro pen page.

Payment is by Visa or Mastercard, Klarna, or pay-monthly options, and there are no subscriptions, so you are never locked in. Repeat orders re-check suitability and there is no auto-shipping, which means a decision to change dose, pause or stop is always yours to make with your prescriber.

Our GLPTrackr companion app is free and helps you track your GLP-1 journey, including weight, injections and notes, so you have a clean record to bring to a review. If you would like to understand the person-by-person reasons behind a stall, our guide on why someone would not lose weight on Mounjaro is a good next read.